메뉴 건너뛰기




Volumn 99, Issue 9, 2013, Pages 626-633

Impact of Overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: Pooled analysis of five trials from the international Global Resolute Program

(16)  Farooq, Vasim a   Vranckx, Pascal a   Mauri, Laura b   Cutlip, Donald E c   Belardi, Jorge d   Silber, Sigmund e   Widimsky, Petr f   Leon, Martin g   Windecker, Stephan h   Meredith, Ian i   Negoita, Manuela j   Van Leeuwen, Frank j   Neumann, Franz Joseph k   Yeung, Alan C l   Garcia Garcia, Hector M a   Serruys, Patrick W a  


Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS;

EID: 84876151235     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-303368     Document Type: Article
Times cited : (33)

References (49)
  • 3
    • 33646045590 scopus 로고    scopus 로고
    • Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention
    • Chu WW, Kuchulakanti PK, Torguson R, et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2006;67:595-9.
    • (2006) Catheter Cardiovasc Interv , vol.67 , pp. 595-599
    • Chu, W.W.1    Kuchulakanti, P.K.2    Torguson, R.3
  • 4
    • 80052165059 scopus 로고    scopus 로고
    • Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents
    • Her SH, Yoo KD, Park CS, et al. Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents. Heart 2011;97:1501-6.
    • (2011) Heart , vol.97 , pp. 1501-1506
    • Her, S.H.1    Yoo, K.D.2    Park, C.S.3
  • 5
    • 77949283671 scopus 로고    scopus 로고
    • Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation
    • Raber L, Juni P, Loffel L, et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 2010;55:1178-88.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1178-1188
    • Raber, L.1    Juni, P.2    Loffel, L.3
  • 6
    • 77954746572 scopus 로고    scopus 로고
    • Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents
    • Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2010;3:531-9.
    • (2010) JACC Cardiovasc Interv , vol.3 , pp. 531-539
    • Guagliumi, G.1    Musumeci, G.2    Sirbu, V.3
  • 7
    • 79960601139 scopus 로고    scopus 로고
    • Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: The LongOCT study (Optical Coherence Tomography in Long Lesions)
    • Guagliumi G, Ikejima H, Sirbu V, et al. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions). JACC Cardiovasc Interv 2011;4:778-85.
    • (2011) JACC Cardiovasc Interv , vol.4 , pp. 778-785
    • Guagliumi, G.1    Ikejima, H.2    Sirbu, V.3
  • 8
    • 84876117460 scopus 로고    scopus 로고
    • TCT-33 Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The Potential Implications for Clinical Practice
    • In Press
    • Farooq V, Heo HJ, Gogas B, et al. TCT-33 Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The Potential Implications for Clinical Practice. JACC Interventions (In Press).
    • JACC Interventions
    • Farooq, V.1    Heo, H.J.2    Gogas, B.3
  • 9
    • 0037303940 scopus 로고    scopus 로고
    • Drug eluting stents: Are human and animal studies comparable?
    • Virmani R, Kolodgie FD, Farb A, et al. Drug eluting stents: are human and animal studies comparable? Heart 2003;89:133-8. (Pubitemid 36115090)
    • (2003) Heart , vol.89 , Issue.2 , pp. 133-138
    • Virmani, R.1    Kolodgie, F.D.2    Farb, A.3    Lafont, A.4
  • 10
    • 84858309763 scopus 로고    scopus 로고
    • One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry
    • Neumann FJ, Widimsky P, Belardi JA. One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry. EuroIntervention 2012;7:1181-8.
    • (2012) EuroIntervention , vol.7 , pp. 1181-1188
    • Neumann, F.J.1    Widimsky, P.2    Belardi, J.A.3
  • 11
    • 79953735235 scopus 로고    scopus 로고
    • Unrestricted randomised use of two new generation drug-eluting coronary stents:2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
    • Silber S, Windecker S, Vranckx P, et al. Unrestricted randomised use of two new generation drug-eluting coronary stents:2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet 2011;377:1241-7.
    • (2011) Lancet , vol.377 , pp. 1241-1247
    • Silber, S.1    Windecker, S.2    Vranckx, P.3
  • 12
    • 79955056445 scopus 로고    scopus 로고
    • Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: The RESOLUTE US clinical trial
    • Yeung AC, Leon MB, Jain A, et al. Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. J Am Coll Cardiol 2011;57:1778-83.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1778-1783
    • Yeung, A.C.1    Leon, M.B.2    Jain, A.3
  • 13
    • 70350020760 scopus 로고    scopus 로고
    • Clinical and angiographic results with the next-generation resolute stent system: A prospective, multicenter, first-in-human trial
    • Meredith IT, Worthley S, Whitbourn R, et al. Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv 2009;2:977-85.
    • (2009) JACC Cardiovasc Interv , vol.2 , pp. 977-985
    • Meredith, I.T.1    Worthley, S.2    Whitbourn, R.3
  • 15
    • 77954392890 scopus 로고    scopus 로고
    • Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
    • Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010;363:136-46.
    • (2010) N Engl J Med , vol.363 , pp. 136-146
    • Serruys, P.W.1    Silber, S.2    Garg, S.3
  • 16
    • 84872086285 scopus 로고    scopus 로고
    • Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation
    • Vranckx P, McFadden E, Cutlip DE, et al. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. Contemp Clin Trials 2012;8:368-74.
    • (2012) Contemp Clin Trials , vol.8 , pp. 368-374
    • Vranckx, P.1    McFadden, E.2    Cutlip, D.E.3
  • 17
    • 84872086285 scopus 로고    scopus 로고
    • Clinical event committees in coronary stent trials: Insights and recommendations based on experience in an unselected study population
    • Vranckx P, McFadden E, Mehran R, et al. Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population. EuroIntervention 2012;8:368-74.
    • (2012) EuroIntervention , vol.8 , pp. 368-374
    • Vranckx, P.1    McFadden, E.2    Mehran, R.3
  • 18
    • 79955073346 scopus 로고    scopus 로고
    • Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial)
    • Mauri L, Leon MB, Yeung AC, et al. Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). Am Heart J 2011;161:807-14.
    • (2011) Am Heart J , vol.161 , pp. 807-814
    • Mauri, L.1    Leon, M.B.2    Yeung, A.C.3
  • 19
    • 84866057851 scopus 로고    scopus 로고
    • Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: Impact on outcome reporting
    • Vranckx P, Farooq V, Garg S, et al. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting. Heart 2012;98:1424-30.
    • (2012) Heart , vol.98 , pp. 1424-1430
    • Vranckx, P.1    Farooq, V.2    Garg, S.3
  • 20
    • 77954399153 scopus 로고    scopus 로고
    • Myocardial infarction adjudication in contemporary all-comer stent trials: Balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies
    • Vranckx P, Cutlip DE, Mehran R, et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention 2010;5:871-4.
    • (2010) EuroIntervention , vol.5 , pp. 871-874
    • Vranckx, P.1    Cutlip, D.E.2    Mehran, R.3
  • 23
    • 29344457180 scopus 로고    scopus 로고
    • ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
    • Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-21.
    • (2006) J Am Coll Cardiol , vol.47
    • Smith Jr., S.C.1    Feldman, T.E.2    Hirshfeld Jr., J.W.3
  • 24
    • 33644775142 scopus 로고    scopus 로고
    • Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: Support for the use of drug-eluting stents in contemporary clinical practice
    • DOI 10.1161/CIRCULATIONAHA.105.552190, PII 0000301720051122000016
    • Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005;112:3306-13. (Pubitemid 43739376)
    • (2005) Circulation , vol.112 , Issue.21 , pp. 3306-3313
    • Dawkins, K.D.1    Grube, E.2    Guagliumi, G.3    Banning, A.P.4    Zmudka, K.5    Colombo, A.6    Thuesen, L.7    Hauptman, K.8    Marco, J.9    Wijns, W.10    Popma, J.J.11    Koglin, J.12    Russell, M.E.13
  • 26
    • 77949290735 scopus 로고    scopus 로고
    • Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents
    • Dawkins KD Grube E, Guagliumi G, et al. Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. EuroIntervention 2007;3:213-21.
    • (2007) EuroIntervention , vol.3 , pp. 213-221
    • Dawkins, K.D.1    Grube, E.2    Guagliumi, G.3
  • 27
    • 64849085105 scopus 로고    scopus 로고
    • Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: Results from a single-center registry in 318 consecutive patients
    • Ruchin PE, Trabattoni D, Fabbiocchi F, et al. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients. Int J Cardiol 2009;134:231-7.
    • (2009) Int J Cardiol , vol.134 , pp. 231-237
    • Ruchin, P.E.1    Trabattoni, D.2    Fabbiocchi, F.3
  • 29
    • 67651119696 scopus 로고    scopus 로고
    • Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in porcine coronary arteries
    • 1-2
    • Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-9, 1-2.
    • (2009) Circulation , vol.120 , pp. 141-149
    • Wilson, G.J.1    Nakazawa, G.2    Schwartz, R.S.3
  • 30
    • 74549129104 scopus 로고    scopus 로고
    • An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: A LEADERS trial sub-study
    • Barlis P, Regar E, Serruys PW, et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J 2010;31:165-76.
    • (2010) Eur Heart J , vol.31 , pp. 165-176
    • Barlis, P.1    Regar, E.2    Serruys, P.W.3
  • 31
    • 73949122498 scopus 로고    scopus 로고
    • Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial
    • Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 2010;375:201-9.
    • (2010) Lancet , vol.375 , pp. 201-209
    • Kedhi, E.1    Joesoef, K.S.2    McFadden, E.3
  • 32
    • 84861482050 scopus 로고    scopus 로고
    • Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: Comparison with sirolimus-eluting stent using optical coherence tomography
    • Choi HH, Kim JS, Yoon DH, et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2012;28:491-7.
    • (2012) Int J Cardiovasc Imaging , vol.28 , pp. 491-497
    • Choi, H.H.1    Kim, J.S.2    Yoon, D.H.3
  • 33
    • 80054071576 scopus 로고    scopus 로고
    • Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. A fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: An optical coherence tomography substudy from the RESOLUTE All Comers trial
    • Gutierrez-Chico JL, van Geuns RJ, Regar E, et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011;32:2454-63.
    • (2011) Eur Heart J , vol.32 , pp. 2454-2463
    • Gutierrez-Chico, J.L.1    Van Geuns, R.J.2    Regar, E.3
  • 34
    • 80051759292 scopus 로고    scopus 로고
    • Restenosis: Delineating the numerous causes of drug-eluting stent restenosis
    • Farooq V, Gogas BD, Serruys PW. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv 2011;4:195-205.
    • (2011) Circ Cardiovasc Interv , vol.4 , pp. 195-205
    • Farooq, V.1    Gogas, B.D.2    Serruys, P.W.3
  • 37
    • 70449556979 scopus 로고    scopus 로고
    • Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents:1-year results of the PAINT trial
    • Lemos PA, Moulin B, Perin MA, et al. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents:1-year results of the PAINT trial. Catheter Cardiovasc Interv 2009;74:665-73.
    • (2009) Catheter Cardiovasc Interv , vol.74 , pp. 665-673
    • Lemos, P.A.1    Moulin, B.2    Perin, M.A.3
  • 38
    • 42049104505 scopus 로고    scopus 로고
    • The next-generation Endeavor Resolute stent:4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial
    • Meredith IT, Worthley S, Whitbourn R, et al. The next-generation Endeavor Resolute stent:4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial. EuroIntervention 2007;3:50-3.
    • (2007) EuroIntervention , vol.3 , pp. 50-53
    • Meredith, I.T.1    Worthley, S.2    Whitbourn, R.3
  • 41
    • 65249097748 scopus 로고    scopus 로고
    • Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: A report from the SCAAR (Swedish Angiography and Angioplasty Registry)
    • Frobert O, Lagerqvist B, Carlsson J, et al. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). J Am Coll Cardiol 2009;53:1660-7.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1660-1667
    • Frobert, O.1    Lagerqvist, B.2    Carlsson, J.3
  • 42
    • 84859345559 scopus 로고    scopus 로고
    • Role of endothelial shear stress in stent restenosis and thrombosis: Pathophysiologic mechanisms and implications for clinical translation
    • Koskinas KC, Chatzizisis YS, Antoniadis AP, et al. Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation. J Am Coll Cardiol 2012;59:1337-49.
    • (2012) J Am Coll Cardiol , vol.59 , pp. 1337-1349
    • Koskinas, K.C.1    Chatzizisis, Y.S.2    Antoniadis, A.P.3
  • 43
    • 79952057270 scopus 로고    scopus 로고
    • Bioresorbable scaffold: The advent of a new era in percutaneous coronary and peripheral revascularization?
    • Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011;123:779-97.
    • (2011) Circulation , vol.123 , pp. 779-797
    • Onuma, Y.1    Serruys, P.W.2
  • 44
    • 84878529444 scopus 로고    scopus 로고
    • Bioresorbable scaffolds: Current knowledge, potentialities and limitations experienced during their first clinical applications
    • Jun. 28. Epub ahead of print
    • Bourantas CV, Onuma Y, Farooq V, et al. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol 2012 Jun. 28. (Epub ahead of print).
    • (2012) Int J Cardiol
    • Bourantas, C.V.1    Onuma, Y.2    Farooq, V.3
  • 45
    • 72249120556 scopus 로고    scopus 로고
    • Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents
    • Popma JJ, Mauri L, O'Shaughnessy C, et al. Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interv 2009;2:133-9.
    • (2009) Circ Cardiovasc Interv , vol.2 , pp. 133-139
    • Popma, J.J.1    Mauri, L.2    O'Shaughnessy, C.3
  • 46
    • 79954538234 scopus 로고    scopus 로고
    • Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: Three-year results from the SPIRIT III randomised trial
    • Lansky AJ, Yaqub M, Hermiller JB, et al. Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention 2010;6(Suppl J):J44-52.
    • (2010) EuroIntervention , vol.6 , Issue.SUPPL. J
    • Lansky, A.J.1    Yaqub, M.2    Hermiller, J.B.3
  • 47
    • 84876103567 scopus 로고    scopus 로고
    • Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: An interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials
    • In press
    • Muramatsu T, Onuma Y, Garcia-Garcia HM, et al. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: An interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Interventions (In press).
    • JACC Interventions
    • Muramatsu, T.1    Onuma, Y.2    Garcia-Garcia, H.M.3
  • 49
    • 58349112528 scopus 로고    scopus 로고
    • Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
    • Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.
    • (2009) N Engl J Med , vol.360 , pp. 213-224
    • Tonino, P.A.1    De Bruyne, B.2    Pijls, N.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.